Tweed Looks to Control Nearly Half of Canadian Cannabis Market

The Canadian medical cannabis industry is expected to reach $1.3 billion in size by 2024, according to Health Canada, with over 400,000 patients joining over the next nine years. With about 16 licensed producers under the new MMPR program, the market has been heating up following the Canadian Supreme Court’s ruling that cleared... more →
Posted in: Press

Testing the Limits: DigiPath Labs Targets Booming Nevada MMJ Market

Nevada legalized medical marijuana back in 2000, but dispensaries weren’t permitted until Senate Bill 374 passed 13 years later. With the state’s large tourism industry, and the most liberal medical marijuana reciprocity laws in the country, the Nevada market could see rapid expansion over the coming years and grow into... more →
Posted in: Press

BreedIT and Seach Leverage Designer Strains to Better Cure

The benefits of medical cannabis are becoming increasingly apparent as companies like GW Pharmaceuticals plc (GWPH) publish the results of the clinical trials for their cannabinoid-based medicines. For example, their Epidiolex has shown tremendous potential in treating Dravet and Lennox-Gastaut syndromes. The creation of protocols... more →
Posted in: Press

Tweed Is Aiming To Expand Pot Operations In Europe

Just as news broke of Tweed Marijuana Inc.’s co-founder and former CEO resigning from its board of governors, company chairman Bruce Linton told a crowd at Carleton University the medical marijuana provider is considering expanding operations in Europe. In a statement issued Thursday morning, the company said Chuck Rifici was... more →
Posted in: News

Canada Investment Watchdog Gives Warning About Medical Marijuana Scams

Investors interested to place investment in marijuana stocks should know that only 13 companies so far have been licensed by the Health Canada, a federal department, to cultivate marijuana and market it to patients who have a doctor’s prescription. “Investors should be aware that companies cannot legally conduct a medical... more →
Posted in: Investing

Tweed Marijuana, Inc. Delivers Its First Medical Marijuana Orders

Tweed Marijuana, Inc. (TSXV: TWD) is pleased to announce that its wholly owned subsidiary Tweed Inc. (“Tweed”) has shipped its first orders of medical marijuana to customers. The product, which has been produced in Tweed’s Smiths Falls facility from “seed to sale”, has been tested by Tweed to be in conformance... more →
Posted in: News

GHG Flying As Abattis Is Building An Empire

Speaking of big names, Tweed ( TSX:V.TWD , Stock Forum ) has brought in a bought financing deal worth potentially $19.5 million for ‘facility expansions and general corporate purposes’, at $3.20 per share. The company, which is taking orders, backfilling with old-system-bought product, and generally dominating the scene... more →
Posted in: News

Tweed Marijuana Stocks: 3rd Most Traded In Canada Went Up To 183% Last Friday

Over the weekend, the Smith Falls, Ontario-based company disclosed that it purchased over 60 new strains of medical marijuana seeds and plants from licensed growers. The firm’s current market value is $89 million. Tweed will sell 25 strains to Canadian patients for $5-$12 per gramme, shipping included. Minimum order is 1 gramme,... more →
Posted in: Investing
1 2